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Abstract
Background: Oxidative stress due to the overproduction of nitric oxide (NO) and other oxygen reactive species
(ROS), play a main role in the initiation and progression of the OA disease and leads to the degeneration of
mitochondria. Therefore, the goal of this work is to describe the difference in telomere length of peripheral blood
leukocytes (PBLs) and Nitric Oxide (NO) production between mitochondrial DNA (mtDNA) haplogroup J and non-J
carriers, as indirect approaches of oxidative stress.
Methods: The telomere length of PBL was analyzed in DNA samples from 166 healthy controls (114 J and 52 non-
J) and 79 OA patients (41 J and 38 non-J) by means of a validated qPCR method. The NO production was assessed
in 7 carriers of the haplogroup J and 27 non-J carriers, by means of the colorimetric reaction of the Griess reagent
in supernatants of cultured chondrocytes. Inducible nitric oxide synthase (iNOS) mRNA from these samples was
analyzed by qPCR. Appropiated statistical analyses were performed
Results: Carriers of the haplogroup J showed a significantly longer telomere length of PBLs than non-J carriers,
regardless of age, gender and diagnosis (p = 0.025). Cultured chondrocytes carrying the mtDNA haplogroup J also
showed a lower NO production than non-J carriers (p = 0.043). No significant correlations between age and
telomore length of PBLs were detected neither for carriers of the haplogroup J nor for non-J carriers. A strong
positive correlation between NO production and iNOS expression was also observed (correlation coefficient =
0.791, p < 0.001).
Conclusion: The protective effect of the mtDNA haplogroup J in the OA disease arise from a lower oxidative stress
in carriers of this haplogroup, since this haplogroup is related to lower NO production and hence longer telomere
length of PBLs too.
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Background
Osteoarthritis (OA), the most common form of joint dis-
ease and cause of musculoskeletal disability in elderly
people, is a disease affecting articular cartilage, bone and
soft tissue leading to joint destruction and severe impair-
ment of mobility [1]. It is also the main cause of work
incapacity and one of the most common reasons for visit-
ing primary physicians. The metabolic and structural
changes that take place in the articular cartilage, includ-
ing the reactive oxygen and nitrogen species (RONS), are
thought to play a main role in the initiation and progres-
sion of this disease.
Ag r o w i n gb o d yo fe v i d e n c es u g g e s t st h a to x i d a t i v e
damage, due to the overproduction of nitric oxide (NO)
and other reactive oxygen species (ROS), may be involved
in the pathogenesis of OA [2,3]. The increased levels of
these ROS have been correlated to increased levels of
inflammatory cytokines, such as interleukin-1 (IL-1),
which is implicated in the degeneration of cartilage due
to its induction of proteoglycan loss and matrix degrada-
tion [4]. Both IL-1 and mechanical loading of cartilage
increase the production of NO by upregulating the nitric
oxide synthase 2 [5]; and most of the destructive effects
of NO in articular cartilage are related to the ability of
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-) to generate
peroxynitrite (ONOO
-) [6,7].
RONS can have multiple effects on chondrocytes, but
are associated with oxidative damage to DNA, proteins
and lipids, resulting in a loss of extracellular matrix and
cell death [2,8,9]. However, the most direct effect of NO is
the inhibition of adenosine triphosphate (ATP) produc-
tion, by competing with oxygen to bind to cytochrome
oxidase on the mitochondria, thereby inhibiting the elec-
tron transport chain and the generation of ATP [10,11].
This latter aspect would strengthen the role of the mito-
chondria in the OA disease, as previously described
[6,12-15].
The mtDNA haplogroups have been associated not only
with several multifactorial diseases [16-18] and ageing
[19,20], but also with OA; people carrying the mtDNA
haplogroup J show lower prevalence and severity of knee
and hip OA [14,21]. Besides, they modulate the serum
levels of some collagen type-II molecular biomarkers [22]
as well as some proteolytic enzymes, such as metallopro-
teinases [23]. The proposed mechanism relies on the dif-
ferent metabolic characteristics of these haplogroups,
reflected by the performance of the mitochondrial oxida-
tive phosphorylation system (OXPHOS) of each hap-
logroup [16,24], as well as the lower oxygen consumption
and lower oxidative damage in carriers of the mtDNA
haplogroup J [25].
Telomeres are capping structures at chromosome ends
that prevent the recognition of natural chromosome ends
as DNA double strand breaks. After several cell doublings,
excessive telomere shortening triggers a checkpoint, lead-
ing to apoptosis. However, it has also been reported that
oxygen free radicals (O2
- and ONOO
-) directly injure the
guanine repeats in the telomere DNA, indicating that oxi-
dative stress directly leads to telomere erosion, regardless
of cell division [26,27].
Taking into account that mtDNA haplogroup J is less
prone to suffer oxidative stress than the rest of mitochon-
drial haplogroups, as previously proposed [24,28,29], the
aim of this study was to evaluate if this mtDNA hap-
logroup is correlated with both the telomere length of per-
ipheral blood leukocytes (PBL) and the NO production,
two oxidative stress-related features. In order to demon-
strate this, we measured the telomere length of peripheral
blood leukocytes (PBLs) in a large cohort of samples (OA
patients and healthy controls), and assessed the NO pro-
duction and inducible Nitric oxide synthase (iNOS)
expression in cultured chondrocytes.
Methods
Samples obtention
For telomere length, DNA from healthy (hip OA-free)
control population (n = 115; mean age = 43.13 ± 12.47
years; range: 19-68) was provided by Banco Nacional de
ADN (University of Salamanca, Spain), and also by Hos-
pital Universitario A Coruña ((n = 79 OA patients; mean
age = 69.46 ± 8.97 years; range: 42-95) and (n = 51
healthy controls; mean age = 71 ± 14.48; range: 42-93)).
Total of 166 healthy controls (89 females and 77 males),
114 had the haplogroup J and 52 were non-J carriers; of
the 79 OA patients (54 females and 25 males), 41 had the
haplogroup J and 38 were non-J carriers. Those healthy
controls from Banco Nacional de ADN consisted of a
population sample on which only those individuals who
did not suffer from symptomatic hip OA neither had
been diagnosed of hip OA at the moment of the study
were selected. The cohort from A Coruña include hip
OA patients with different radiographic K-L grades, and
controls free of hip OA as assessed by anamnesis, a clini-
cal examination and radiographic studies.
For NO production and iNOS expression, the cartilage
samples were also obtained from Hospital Universitario A
Coruña: OA cartilage was obtained from the femoral
heads of 24 OA patients (12 females and 12 males) who
underwent joint replacement surgery (mean age = 73.61 ±
8.39 years; range: 57-90), and normal human cartilage was
obtained from autopsy from 10 cadavers (6 females and 4
males) who had no history of joint disease and who had
macroscopically normal cartilage, as well as from patients
who suffered hip fracture and underwent hip replacement
surgery (mean age = 63.90 ± 14.26 years; range: 45-83). Of
the 24 OA patients, 4 have the haplogroup J and 20 are
non-J carriers; of the 10 healthy controls, 3 have the hap-
logroup J and 7 are non-J carriers. Informed consent was
obtained from all participants, and this study was
approved by ethics committee of Galicia (reference num-
ber 2008/141).
DNA isolation
DNA from samples obtained in our facilities was extracted
using the Magtration System12CG (Precision System
Science Co., Ltd., Matsudo, Chiba, Japan) using Magtra-
tion-MagaZorb DNA Common Kit-200 N reagents, and
then quantified using the NanoDrop ND-1000 Spectro-
photometer (NanoDrop Technologies, Wilmington, Dela-
ware, USA). Coded DNA samples were processed by
personnel blinded to the status of the subjects. The iso-
lated DNA was used to perform both the assignment of
the mtDNA haplogroups and the telomere quantification.
Assignment of mtDNA haplogroups
The samples obtained for the present study were hap-
logroup-typed using a previously described assay [14].
Telomere quantification
The average telomere length of PBL was measured with
a validated quantitative (Q-PCR)-based assay using a
LightCycler 480 thermalcycler (Roche Diagnostics
®,
Fernández-Moreno et al. BMC Musculoskeletal Disorders 2011, 12:283
http://www.biomedcentral.com/1471-2474/12/283
Page 2 of 7Laval, Quebec, Canada) in a 96-well format, as described
in Tamayo et al [30]. This method measures the average
ratio of telomere repeat copy number to a single gene
(36B4) copy number (T/S ratio) in each sample.
Chondrocytes culture and NO production
The chondrocytes culture was performed as described in
Maneiro et al [12]. Briefly, the dissected cartilage was
incubated at 37°C with trypsin for 10 minutes. After
removing trypsin solution, the cartilage slices were trea-
ted with type IV collagenase (2 mg/mL; SIGMA, St.
Louis, MO) for 12-16 hours. Human chondrocytes were
recovered and plated in Dulbecco’s modified Eagle’s
medium (Life technologies, Paisley, UK) supplemented
with 100 units/ml penicillim, 100 μg/mL streptomycin
and 10% fetal bovine serum (FBS) (Life technologies).
Chondrocytes were incubated at 37°C in a humidified gas
mixture containing 5% CO2.
When human chondrocytes reached the confluency, a
total of 5 × 10
4 cells were collected by trypsinization and
plated in 96-well plates with Dulbecco’s modified Eagle’s
medium supplemented with 100 units/ml penicillin,
100 μg/mL streptomycin and 10% FBS for 24 hours. In
order to measure the NO production, the FBS of the med-
ium was changed to a concentration of 0,5% for 48 hours,
after which the assessment of the NO production was car-
ried out. The measure was performed by an indirect
method in supernatants of each sample by duplicate by
means of the colorimetric reaction of the Griess reagent
(Enzo Life Sciences, Farmingdale, New York, USA), using
a standard curve with NaNO2. The absorbencies emitted
were captured in a spectrophotometer (Labsystems Multis-
kan
® Plus).
iNOS expression
RNA was isolated from the above cultured cells (5 × 10
5)
following the Trizol (Invitrogen
®, Life Technologies,
Paisley, UK)-based method. Isolated and DNase-treated
RNA (1000 ng) was retrotranscribed to cDNA using the
Transcriptor First Strand cDNA synthesis Kit from
Roche Diagnostics
® following the manufacturer’s
recommendations.
The real-time PCR was performed using a LightCycler
480 thermalcycler in a 96-well format. Duplicate cDNA
samples were amplified in para l l e li naf i n a lv o l u m eo f
20 μL, that included 5 μLc D N A ,1 0μL of LightCycler
®
480 Sybr Green I Master (Roche Diagnostics
®), 0.25 μL
Uracil-DNA glycosylase (UDG) to prevent carry-over
contaminations (Roche Diagnostics) and 0.3 μMo fs p e -
cific primers for iNOS (forward: 5’-gctgccaagctgaaattga-
3’; reverse: 5’-gatagcgcttctggctcttg-3’) and the reference
gene HPRT (forward: 5’-tgaccttgatttattttgcatacc-3’;
reverse: 5’-cgagcaagacgttcagtcct-3’). After two previous
steps of 40°C for 10 minutes, to activate the UDG, and
95°C for 10 minutes to activate the Taq polymerase, the
mixture was amplified as follows: 55 cycles at 95°C for
10 seconds, 60°C for 15 seconds and 72°C for 10 sec-
onds; with a final extension of 72°C for 1 minute. The
specificity of all reactions was determined by melting
point curve analysis using one cycle at 95°C for 5 sec-
onds and 65°C for 1 minute followed by a heating up
step to 97°C in a continuous way of fluorescence
acquisition.
Statistical analyses
Statistical analyses were performed using SPSS software,
release 17 (Chicago, USA) and Relative Expression Soft-
ware Tool (REST), release 1.9.9 [31]. A non-parametric
study was performed, utilizing the Mann-Whitney
U-test, to compare the telomere length of PBL between
OA patients and healthy controls, as well as between
haplogroup J carriers and non-J carriers. The same sta-
tistical approach was used to compare the NO produc-
tion and iNOS expression between haplogroup J and
non-J carriers.
Following the above approach, an analysis of covar-
iance (ANCOVA) was used to evaluate the effects of
haplogroup J on telomere length, adjusting for the con-
founder effects of diagnosis, gender and covariate age.
ANCOVA assumptions were tested in each case and no
violations were found. Before the multivariate analysis, a
distribution analysis using the Kolmogorov-Smirnov test
showed that the telomere length data were normally dis-
tributed. Additionally, we also performed a Spearman’s
correlation test and subsequent scatterplots to analyze
possible correlations between age and telomere length
in both J and non-J carriers.
Finally, the data from the real time PCR experiments
were analyzed using REST software, which uses boot-
strap randomization techniques to determine whether
an observed up or down-regulation in samples is signifi-
cant after normalization to housekeepers. To test the
correlation between the iNOS expression and the NO
production, a Spearman’s correlation analysis was
performed.
Results
Telomere length
The non-parametric analysis of the telomere length of
PBL between OA patients and healthy controls showed
that OA patients had a shorter telomere length than
healthy controls (0.986 vs 1.008 respectively), however
this difference did not reach the statistical significance
between both groups (Table 1). Interestingly, the mean
telomere length for all the mtDNA haplogroups showed
that carriers of the haplogroup J had a significantly
longer length than non-J carriers (1.039 vs 0.933 respec-
tively) (p = 0.003) (Table 1).
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assess the effects of the mtDNA haplogroup J and other
variables such as diagnosis, gender and age on the telo-
mere length of PBL. The results obtained also reflected
that carriers of the mtDNA haplogroup J showed a sig-
nificantly longer telomere length than non-J carriers
(p = 0.025) (Figure 1). The rest of variables tested such
as age, gender and diagnosis did not show any influence
on the telomere length of PBLs.
Despite age was not associated with telomere length in
this study, we also performed a Spearman’sc o r r e l a t i o n
test and subsequent scatterplots for both J and non-J
carriers. The results obtained did not show correlation
between age and telomere length of PBLs neither in car-
riers of the haplogroup J neither in non-J carriers,
strengthening the results obtained in the multiple
regression analysis (Figure 2a and 2b).
NO production and iNOS expression
The results obtained showed that mean NO production
was significantly lower in haplogroup J carriers when
compared with non-J carriers (17.75 vs 47.30 respectively;
p = 0.043) (Figure 3). The expression of iNOS in carriers
of haplogroup J was (not significantly) lower than in non-J
carriers (Figure 4). In addition, a strong positive correla-
tion between the NO production and the expression of
iNOS was also demonstrated (correlation coefficient 0.791,
p-value < 0.001) (Figure 5).
Discussion
To our knowledge, this is the first study to correlate the
telomere length with the mtDNA haplogroups, showing
that carriers of the mtDNA haplogroup J have a longer tel-
omere length of PBLs than non-J carriers. The results
o b t a i n e da l s os h o w e dt h a tc u l t u r e dc h o n d r o c y t e st h a t
carry the mtDNA haplogroup J show lower NO produc-
tion and lower levels of iNOS than non-J carriers.
There are several studies that analyzed the telomerase
activity in OA that showed that the presence of oxidative
stress induces telomere genomic instability, replicative
senescence and dysfunction of chondrocytes in OA carti-
lage [27]. On the contrary, other study proposes that the
role of telomerase in the OA pathogenesis is still uncer-
tain [32]. A recent work reported that telomere length of
PBLs seemed not to be influenced by local OA pathology,
confirming our present results; nevertheless, other rheu-
matologic diseases with higher and systemic inflamma-
tory component, such as rheumatoid arthritis (RA),
psoriatic arthritis (PA) and ankylosing spondilytis (AS)
affected telomere length of PBLs, so that these patients
showed longer telomere length than healthy controls
[30]. However, the telomere length in OA chondrocytes
is significantly shorter than in healthy aged chondrocytes,
which may imply a local advance senescence that could
contribute to the pathogenesis or progression of the OA
disease [33].
It has been previously described that oxidative stress
leads to telomere erosion, regardless of cell division, and
that IL-1, one of the main pro-inflammatory cytokines
involved in the OA process, stimulates NO production
leading to the formation of ONOO
-, which targets gua-
nine repeats in DNA telomeres [26,27,34]. NO has been
previously described to be increased in OA chondrocytes
[35-37], and our results confirmed these findings (data
not shown). In this sense, a work carried out by our
group showed that carriers of the mtDNA haplogroup J
have lower serum levels of Coll2-1NO2 than carriers of
the haplogroup H [22] and, because the effect of NO on
chondrocyte survival has been shown to be mediated by
its effect on the mitochondrial respiratory chain [11], and
Coll2-1NO2 is an indicator of oxidative stress status of
t h ec h o n d r o c y t e[ 3 8 ] ,t h e s ef indings suggest that chon-
drocytes carrying the haplogroup J may have less oxida-
tive stress. This latter conclusion is strengthen in the
present study, since those carriers of the mtDNA
Table 1 Mean telomere length in OA patients and
healthy controls and in carriers of the mtDNA
haplogroup J
n Mean age ± SD T/S ratio ± SD p*
OA patients 79 69.46 ± 8.97 0.986 ± 0.261 0.684
Healthy controls 166 51.92 ± 18.45 1.008 ± 0.287
Haplogroup J 155 52.97 ± 17.60 1.039 ± 0.287 0.003**
Non-J 90 65.22 ± 15.98 0.933 ± 0.254
(*) Mann-Whitney non-parametric U-test
(**) indicates statistical significance (p ≤ 0.05)
SD = Standard deviation
Figure 1 Multiple regression analysis. Telomere length between
haplogroup J (n = 155) and non-J carriers (n = 90). (**: multiple
regression analysis).
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PBLs, but also lower NO production and lower iNOS
expression in cultured chondrocytes. However, we must
point out that the telomere length was measured in PBLs
and the NO production in cultured chondrocytes, there-
fore a direct correlation cannot be determined, but it is
possible to speculate it since both cell types have in com-
mon the haplogroup J.
The proposed explanation would rely on the reduced
coupling efficiency of the OXPHOS system of the
mtDNA haplogroup J. This would reduce maximal ATP
production and keep the mitochondrial electron trans-
port chain more oxidized, thereby reducing ROS produc-
tion and apoptosis [29]. With this scenario, the lower the
O2
- generated, the lower the ONOO
- produced, resulting
in a decreased oxidative damage by RONS and, conse-
quently, the longer the telomere length. Besides, it is well
known that mitochondria is involved in the NO produc-
tion through the reduction of nitrite by cytochrome c
oxidase, and regulated by oxygen on multiple levels
[39,40]; since mtDNA haplogroup J show a lower oxygen
consumption [25], we speculate that this could be one of
the reasons why carriers of this haplogroup show lower
NO production and hence longer telomere length, indi-
cating a decreased oxidative damage. Because of this, the
mtDNA haplogroup J not only protects from the devel-
opment of both knee and hip OA [14,21], but has also
Figure 2 Spearman’s correlation test and scatterplots representing the correlation analysis between age and telomere length of PBLs.
a) non-J carriers and b) haplogroup J carriers. (C.C: correlation coefficient from Spearman’s correlation test).
Figure 3 Mean values of NO. NO production between haplogroup
J (n = 7) and non-J carriers (n = 27). (**: Mann-Whitney U test).
Figure 4 Relative values of iNOS. mRNA levels between
haplogroup J (n = 7) and non-J (n = 27) carriers.
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independent studies [19,20,41,42].
Despite the strong statistical correlation between the
iNOS mRNA expression and the NO production, a
higher variability in the results was detected. This could
be due to i) the existence of different phenotypes of the
O Ad i s e a s ea n d ,a m o n gt h ep o s s i b l ec a u s e st oe x p l a i n
this, the mtDNA haplogroups could be one of them; or
ii) the small sample size regarding to haplogroup J car-
riers. On the contrary, this variability was not detected
when analyzed the telomere length of PBL, and a consis-
tent statistical association between the mtDNA hap-
logroup J and the telomere length was detected, clearly
indicating that cells carrying this haplogroup suffer less
oxidative stress. However, no differences in the telomere
length of PBLs were detected between OA patients and
healthy controls, as described earlier [30].
Conclusion
In summary, this study shows that carriers of the mtDNA
haplogroup J show a significantly higher telomere length
of PBL than non-J carriers, as well as a decreased NO
production and lower iNOS mRNA levels in cultured
chondrocytes, indicating that this haplogroup, which is
clearly biochemically different from those of other popu-
lation-specific mtDNA lineages [43], is associated with
reduced oxidative stress. However, since these two fea-
tures were analyzed in two different cell types, a correla-
tion between the lower NO production and the longer
telomere length cannot be directly determined but it is
possible to speculate it because both cell types have in
common the haplogroup J.
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